{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:47:10Z","timestamp":1793504830415,"version":"4.5.0"},"reference-count":165,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hepatocellular carcinoma is today the sixth leading cause of cancer-related death worldwide, despite the decreased incidence of chronic hepatitis infections. This is due to the increased diffusion of metabolic diseases such as the metabolic syndrome, diabetes, obesity, and nonalcoholic steatohepatitis (NASH). The current protein kinase inhibitor therapies in HCC are very aggressive and not curative. From this perspective, a shift in strategy toward metabolic therapies may represent a promising option. Here, we review current knowledge on metabolic dysregulation in HCC and therapeutic approaches targeting metabolic pathways. We also propose a multi-target metabolic approach as a possible new option in HCC pharmacology.<\/jats:p>","DOI":"10.3390\/ijms24043710","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T03:28:46Z","timestamp":1676258926000},"page":"3710","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy"],"prefix":"10.3390","volume":"24","author":[{"given":"Davide","family":"Gnocchi","sequence":"first","affiliation":[{"name":"Interdisciplinary Department of Medicine, School of Medicine, University of Bari, Piazza G. Cesare 11, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Sabb\u00e0","sequence":"additional","affiliation":[{"name":"Interdisciplinary Department of Medicine, School of Medicine, University of Bari, Piazza G. Cesare 11, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9569-816X","authenticated-orcid":false,"given":"Mara","family":"Massimi","sequence":"additional","affiliation":[{"name":"Department of Life, Health and Environmental Sciences, University of L\u2019Aquila, 67100 L\u2019Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0940-7352","authenticated-orcid":false,"given":"Antonio","family":"Mazzocca","sequence":"additional","affiliation":[{"name":"Interdisciplinary Department of Medicine, School of Medicine, University of Bari, Piazza G. Cesare 11, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","article-title":"The liver","volume":"27","author":"Trefts","year":"2017","journal-title":"Curr. Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejca.2021.11.023","article-title":"Global, regional and national burden of primary liver cancer by subtype","volume":"161","author":"Rumgay","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.bbadis.2017.11.026","article-title":"Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment","volume":"1864","author":"Agosti","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kudo, M. (2018). Systemic Therapy for Hepatocellular Carcinoma: Latest Advances. Cancers, 10.","DOI":"10.3390\/cancers10110412"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The Metabolism of Tumors in the Body","volume":"8","author":"Warburg","year":"1927","journal-title":"J. Gen. Physiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1126\/science.140.3574.1391","article-title":"Cancer therapy: A possible new approach","volume":"140","author":"Hegyeli","year":"1963","journal-title":"Science"},{"key":"ref_11","first-page":"99","article-title":"The living state and cancer","volume":"12","year":"1980","journal-title":"Physiol. Chem. Phys."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/BF01516207","article-title":"Bioelectronics and cancer","volume":"4","year":"1973","journal-title":"J. Bioenerg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1158\/2159-8290.CD-20-0844","article-title":"Targeting Metabolic Plasticity and Flexibility Dynamics for Cancer Therapy","volume":"10","author":"Fendt","year":"2020","journal-title":"Cancer Discov."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1016\/j.molcel.2021.08.005","article-title":"The context-specific roles of urea cycle enzymes in tumorigenesis","volume":"81","author":"Hajaj","year":"2021","journal-title":"Mol. Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00726-021-03052-1","article-title":"Amino acid metabolism as a therapeutic target in cancer: A review","volume":"53","author":"Endicott","year":"2021","journal-title":"Amino Acids"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1113\/JP278810","article-title":"Revisiting the Warburg effect: Historical dogma versus current understanding","volume":"599","author":"Vaupel","year":"2021","journal-title":"J. Physiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: The metabolic requirements of cell proliferation","volume":"324","author":"Cantley","year":"2009","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg Effect: How Does it Benefit Cancer Cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.molcel.2020.12.012","article-title":"Increased demand for NAD(+) relative to ATP drives aerobic glycolysis","volume":"81","author":"Luengo","year":"2021","journal-title":"Mol. Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"698023","DOI":"10.3389\/fonc.2021.698023","article-title":"The Mechanism of Warburg Effect-Induced Chemoresistance in Cancer","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"12486","DOI":"10.1038\/s41598-017-12837-y","article-title":"Role of the Transforming Growth Factor-beta in regulating hepatocellular carcinoma oxidative metabolism","volume":"7","author":"Soukupova","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"20208","DOI":"10.1074\/jbc.M117.809012","article-title":"Lactate-mediated mitoribosomal defects impair mitochondrial oxidative phosphorylation and promote hepatoma cell invasiveness","volume":"292","author":"Lee","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1053\/j.gastro.2019.08.022","article-title":"New High-Throughput Screening Identifies Compounds That Reduce Viability Specifically in Liver Cancer Cells That Express High Levels of SALL4 by Inhibiting Oxidative Phosphorylation","volume":"157","author":"Tan","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"15707","DOI":"10.1038\/s41598-018-33667-6","article-title":"Targeting Mitochondrial Oxidative Phosphorylation Abrogated Irinotecan Resistance in NSCLC","volume":"8","author":"Lee","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Nayak, A.P., Kapur, A., Barroilhet, L., and Patankar, M.S. (2018). Oxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian Cancer. Cancers, 10.","DOI":"10.3390\/cancers10090337"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","article-title":"Oxidative Phosphorylation as an Emerging Target in Cancer Therapy","volume":"24","author":"Ashton","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"113485","DOI":"10.1016\/j.biopha.2022.113485","article-title":"Reprogramming of central carbon metabolism in hepatocellular carcinoma","volume":"153","author":"Xia","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0065-2571(68)90028-9","article-title":"Glycolytic regulation in rat liver and hepatomas","volume":"6","author":"Lo","year":"1968","journal-title":"Adv. Enzym. Regul."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","article-title":"Hypoxia in cancer: Significance and impact on clinical outcome","volume":"26","author":"Vaupel","year":"2007","journal-title":"Cancer Metastasis Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1089\/ars.2007.1628","article-title":"Detection and characterization of tumor hypoxia using pO2 histography","volume":"9","author":"Vaupel","year":"2007","journal-title":"Antioxid. Redox Signal."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"20130676","DOI":"10.1259\/bjr.20130676","article-title":"Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response","volume":"87","author":"McKeown","year":"2014","journal-title":"Br. J. Radiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1478-3231.2006.01243.x","article-title":"Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: Importance of angiopoietin-2 and hypoxia-induced factor-1 alpha","volume":"26","author":"Wada","year":"2006","journal-title":"Liver Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.canlet.2014.09.011","article-title":"2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2","volume":"355","author":"Ma","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"37223","DOI":"10.1074\/jbc.M103069200","article-title":"Site specificity of four pyruvate dehydrogenase kinase isoenzymes toward the three phosphorylation sites of human pyruvate dehydrogenase","volume":"276","author":"Korotchkina","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/j.celrep.2015.10.045","article-title":"Stratification of Hepatocellular Carcinoma Patients Based on Acetate Utilization","volume":"13","author":"Bjornson","year":"2015","journal-title":"Cell Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.1840110120","article-title":"Elevation of facilitated glucose-transporter messenger RNA in human hepatocellular carcinoma","volume":"11","author":"Su","year":"1990","journal-title":"Hepatology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"68381","DOI":"10.18632\/oncotarget.20266","article-title":"SLC2A2 (GLUT2) as a novel prognostic factor for hepatocellular carcinoma","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1517\/14728220903307509","article-title":"GLUT1 as a therapeutic target in hepatocellular carcinoma","volume":"13","author":"Amann","year":"2009","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s12032-011-9841-z","article-title":"Reduced survival of patients with hepatocellular carcinoma expressing hexokinase II","volume":"29","author":"Gong","year":"2012","journal-title":"Med. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41467-017-02733-4","article-title":"Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin","volume":"9","author":"DeWaal","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbrc.2016.05.007","article-title":"High expression of hexokinase domain containing 1 is associated with poor prognosis and aggressive phenotype in hepatocarcinoma","volume":"474","author":"Zhang","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/hep.29202","article-title":"Glyceraldehyde-3-phosphate dehydrogenase promotes liver tumorigenesis by modulating phosphoglycerate dehydrogenase","volume":"66","author":"Liu","year":"2017","journal-title":"Hepatology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"940","DOI":"10.18632\/oncotarget.623","article-title":"Glyceraldehyde-3-phosphate dehydrogenase: A promising target for molecular therapy in hepatocellular carcinoma","volume":"3","author":"Kunjithapatham","year":"2012","journal-title":"Oncotarget"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Wong, C.C., Au, S.L., Tse, A.P., Xu, I.M., Lai, R.K., Chiu, D.K., Wei, L.L., Fan, D.N., Tsang, F.H., and Lo, R.C. (2014). Switching of pyruvate kinase isoform L to M2 promotes metabolic reprogramming in hepatocarcinogenesis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0115036"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.trecan.2017.01.005","article-title":"Glutamine Metabolism in Cancer: Understanding the Heterogeneity","volume":"3","author":"Cluntun","year":"2017","journal-title":"Trends Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1177\/014860719902300509","article-title":"Glutamine transport and human hepatocellular transformation","volume":"23","author":"Bode","year":"1999","journal-title":"JPEN J. Parenter. Enter. Nutr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cmet.2011.12.015","article-title":"The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type","volume":"15","author":"Yuneva","year":"2012","journal-title":"Cell Metab."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Faloppi, L., Scartozzi, M., Bianconi, M., Svegliati Baroni, G., Toniutto, P., Giampieri, R., Del Prete, M., De Minicis, S., Bitetto, D., and Loretelli, C. (2014). The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: Implications for clinical management. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-110"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"7196280","DOI":"10.1155\/2016\/7196280","article-title":"Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New","volume":"2016","author":"Faloppi","year":"2016","journal-title":"BioMed Res. Int."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"47332","DOI":"10.18632\/oncotarget.10119","article-title":"Plasma metabolomic analysis of human hepatocellular carcinoma: Diagnostic and therapeutic study","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00432-014-1888-8","article-title":"Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration","volume":"141","author":"Gao","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jhep.2014.04.035","article-title":"CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathway","volume":"61","author":"Huang","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.metabol.2010.03.006","article-title":"Plasma metabolomic profile in nonalcoholic fatty liver disease","volume":"60","author":"Kalhan","year":"2011","journal-title":"Metabolism"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tibs.2014.06.005","article-title":"The pentose phosphate pathway and cancer","volume":"39","author":"Patra","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcmgh.2017.05.004","article-title":"Identification of the Consistently Altered Metabolic Targets in Human Hepatocellular Carcinoma","volume":"4","author":"Nwosu","year":"2017","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e1980","DOI":"10.1038\/cddis.2015.322","article-title":"Hepatitis B virus stimulates G6PD expression through HBx-mediated Nrf2 activation","volume":"6","author":"Liu","year":"2015","journal-title":"Cell Death Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"E725","DOI":"10.1073\/pnas.1508779113","article-title":"Transketolase counteracts oxidative stress to drive cancer development","volume":"113","author":"Xu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"918","DOI":"10.7150\/jca.27226","article-title":"Downregulation of PDK4 Increases Lipogenesis and Associates with Poor Prognosis in Hepatocellular Carcinoma","volume":"10","author":"Yang","year":"2019","journal-title":"J. Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1038\/sj.onc.1209594","article-title":"Succinate dehydrogenase and fumarate hydratase: Linking mitochondrial dysfunction and cancer","volume":"25","author":"King","year":"2006","journal-title":"Oncogene"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1038\/s41598-018-21361-6","article-title":"Decreased succinate dehydrogenase B in human hepatocellular carcinoma accelerates tumor malignancy by inducing the Warburg effect","volume":"8","author":"Tseng","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Gerresheim, G.K., Roeb, E., Michel, A.M., and Niepmann, M. (2019). Hepatitis C Virus Downregulates Core Subunits of Oxidative Phosphorylation, Reminiscent of the Warburg Effect in Cancer Cells. Cells, 8.","DOI":"10.3390\/cells8111410"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41419-018-0961-7","article-title":"O-GlcNAcylation on Rab3A attenuates its effects on mitochondrial oxidative phosphorylation and metastasis in hepatocellular carcinoma","volume":"9","author":"Wu","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/carcin\/bgz174","article-title":"Mitochondrial miR-181a-5p promotes glucose metabolism reprogramming in liver cancer by regulating the electron transport chain","volume":"41","author":"Zhuang","year":"2020","journal-title":"Carcinogenesis"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cmet.2015.12.004","article-title":"NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism","volume":"23","author":"Chen","year":"2016","journal-title":"Cell Metab."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"5202684","DOI":"10.1155\/2017\/5202684","article-title":"Diabetes Mellitus and Risk of Hepatocellular Carcinoma","volume":"2017","author":"Li","year":"2017","journal-title":"BioMed Res. Int."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bbcan.2017.12.006","article-title":"Obesity linking to hepatocellular carcinoma: A global view","volume":"1869","author":"Gan","year":"2018","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41573-021-00367-2","article-title":"Lipogenesis inhibitors: Therapeutic opportunities and challenges","volume":"21","author":"Batchuluun","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3892\/ijo.2014.2441","article-title":"Lipogenesis in cancer progression (review)","volume":"45","author":"Mounier","year":"2014","journal-title":"Int. J. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/liv.13183","article-title":"Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells","volume":"37","author":"Cao","year":"2017","journal-title":"Liver Int."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"14752","DOI":"10.1038\/srep14752","article-title":"Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma","volume":"5","author":"Nath","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1388-1981(00)00044-5","article-title":"Fatty acid import into mitochondria","volume":"1486","author":"Kerner","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Serviddio, G., Giudetti, A.M., Bellanti, F., Priore, P., Rollo, T., Tamborra, R., Siculella, L., Vendemiale, G., Altomare, E., and Gnoni, G.V. (2011). Oxidation of hepatic carnitine palmitoyl transferase-I (CPT-I) impairs fatty acid beta-oxidation in rats fed a methionine-choline deficient diet. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0024084"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2362.2008.01936.x","article-title":"Alterations of hepatic ATP homeostasis and respiratory chain during development of non-alcoholic steatohepatitis in a rodent model","volume":"38","author":"Serviddio","year":"2008","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"21753","DOI":"10.18632\/oncotarget.7832","article-title":"Systematic review with network meta-analysis: Statins and risk of hepatocellular carcinoma","volume":"7","author":"Zhou","year":"2016","journal-title":"Oncotarget"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jhep.2005.09.022","article-title":"Pamidronate induced anti-proliferative, apoptotic, and anti-migratory effects in hepatocellular carcinoma","volume":"44","author":"Wada","year":"2006","journal-title":"J. Hepatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2012.10.005","article-title":"Statins are associated with a reduced risk of hepatocellular cancer: A systematic review and meta-analysis","volume":"144","author":"Singh","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"490","DOI":"10.5604\/01.3001.0011.7394","article-title":"Potential Molecular Targets of Statins in the Prevention of Hepatocarcinogenesis","volume":"17","author":"Ridruejo","year":"2018","journal-title":"Ann. Hepatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/hepr.12844","article-title":"Clinical outcome and prognostic factors in hepatocellular carcinoma patients with bone metastases medicated with zoledronic acid","volume":"47","author":"Honda","year":"2017","journal-title":"Hepatol. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"9925","DOI":"10.18632\/oncotarget.24066","article-title":"Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice","volume":"9","author":"Yamada","year":"2018","journal-title":"Oncotarget"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1158\/1541-7786.MCR-13-0503","article-title":"Cocarcinogenic effects of intrahepatic bile acid accumulation in cholangiocarcinoma development","volume":"12","author":"Lozano","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.bbadis.2013.07.005","article-title":"Down-regulation of LPCAT expression increases platelet-activating factor level in cirrhotic rat liver: Potential antiinflammatory effect of silybin","volume":"1832","author":"Stanca","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1158\/0008-5472.CAN-13-0308","article-title":"Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics","volume":"73","author":"Huang","year":"2013","journal-title":"Cancer Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ajpath.2010.10.023","article-title":"DNA methylation suppresses expression of the urea cycle enzyme carbamoyl phosphate synthetase 1 (CPS1) in human hepatocellular carcinoma","volume":"178","author":"Liu","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network, Wheeler, D.A., and Roberts, L.R. (2017). Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 169, 1327\u20131341.e23.","DOI":"10.1016\/j.cell.2017.05.046"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"77734","DOI":"10.18632\/oncotarget.20774","article-title":"Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosis","volume":"8","author":"Yeh","year":"2017","journal-title":"Oncotarget"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"eaan2507","DOI":"10.1126\/science.aan2507","article-title":"A pathology atlas of the human cancer transcriptome","volume":"357","author":"Uhlen","year":"2017","journal-title":"Science"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.celrep.2018.03.077","article-title":"Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers","volume":"23","author":"Peng","year":"2018","journal-title":"Cell Rep."},{"key":"ref_89","first-page":"e391","article-title":"Serum albumin levels in relation to tumor parameters in hepatocellular carcinoma patients","volume":"32","author":"Carr","year":"2017","journal-title":"Int. J. Biol. Mrk."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10350","article-title":"Functional genomics reveal that the serine synthesis pathway is essential in breast cancer","volume":"476","author":"Possemato","year":"2011","journal-title":"Nature"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/ng.890","article-title":"Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis","volume":"43","author":"Locasale","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1126\/science.1218595","article-title":"Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation","volume":"336","author":"Jain","year":"2012","journal-title":"Science"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nature11540","article-title":"Serine is a natural ligand and allosteric activator of pyruvate kinase M2","volume":"491","author":"Chaneton","year":"2012","journal-title":"Nature"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ijc.29718","article-title":"Alteration of amino acid and biogenic amine metabolism in hepatobiliary cancers: Findings from a prospective cohort study","volume":"138","author":"Stepien","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"18175","DOI":"10.1038\/srep18175","article-title":"Serum Metabolomics to Identify the Liver Disease-Specific Biomarkers for the Progression of Hepatitis to Hepatocellular Carcinoma","volume":"5","author":"Gao","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1158\/1078-0432.CCR-17-1707","article-title":"Global Metabolic Profiling Identifies a Pivotal Role of Proline and Hydroxyproline Metabolism in Supporting Hypoxic Response in Hepatocellular Carcinoma","volume":"24","author":"Tang","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ni.1937","article-title":"Macrophage plasticity and interaction with lymphocyte subsets: Cancer as a paradigm","volume":"11","author":"Biswas","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12026-012-8291-9","article-title":"Macrophage polarization and plasticity in health and disease","volume":"53","author":"Biswas","year":"2012","journal-title":"Immunol. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.4049\/jimmunol.180.4.2011","article-title":"Plasticity of macrophage function during tumor progression: Regulation by distinct molecular mechanisms","volume":"180","author":"Biswas","year":"2008","journal-title":"J. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2014.08.039","article-title":"Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells","volume":"147","author":"Wan","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ccr.2006.06.016","article-title":"Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment","volume":"10","author":"Budhu","year":"2006","journal-title":"Cancer Cell"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.4049\/jimmunol.1202702","article-title":"Tumor-derived lactate modifies antitumor immune response: Effect on myeloid-derived suppressor cells and NK cells","volume":"191","author":"Husain","year":"2013","journal-title":"J. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e1344804","DOI":"10.1080\/2162402X.2017.1344804","article-title":"Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells","volume":"6","author":"Zheng","year":"2017","journal-title":"Oncoimmunology"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.2147\/OTT.S212465","article-title":"The combination of the glycolysis inhibitor 2-DG and sorafenib can be effective against sorafenib-tolerant persister cancer cells","volume":"12","author":"Wang","year":"2019","journal-title":"OncoTargets Ther."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3892\/ol.2016.5510","article-title":"2-Deoxyglucose and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells","volume":"13","author":"Tomizawa","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"113988","DOI":"10.1016\/j.bcp.2020.113988","article-title":"3-Bromopyruvate regulates the status of glycolysis and BCNU sensitivity in human hepatocellular carcinoma cells","volume":"177","author":"Sun","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1042\/BJ20080805","article-title":"Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate","volume":"417","author":"Kyaw","year":"2009","journal-title":"Biochem. J."},{"key":"ref_110","first-page":"4909","article-title":"Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is pyruvylated during 3-bromopyruvate mediated cancer cell death","volume":"29","author":"Geschwind","year":"2009","journal-title":"Anticancer Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.cmet.2017.08.017","article-title":"A Predictive Model for Selective Targeting of the Warburg Effect through GAPDH Inhibition with a Natural Product","volume":"26","author":"Liberti","year":"2017","journal-title":"Cell Metab."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13046-017-0514-4","article-title":"Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2","volume":"36","author":"Xu","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"45965","DOI":"10.18632\/oncotarget.17469","article-title":"Methyl jasmonate leads to necrosis and apoptosis in hepatocellular carcinoma cells via inhibition of glycolysis and represses tumor growth in mice","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/JHC.S237614","article-title":"Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin through Regulating PKM2","volume":"7","author":"Liu","year":"2020","journal-title":"J Hepatocell. Carcinoma"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/bjc.2017.323","article-title":"Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death","volume":"117","author":"Li","year":"2017","journal-title":"Br. J. Cancer"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1021\/acs.jproteome.8b00029","article-title":"Anti-Cancer Effects of Emodin on HepG2 Cells as Revealed by (1)H NMR Based Metabolic Profiling","volume":"17","author":"Xing","year":"2018","journal-title":"J. Proteome Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1158\/1538-7445.AM2016-3781","article-title":"Combination therapy with a liver selective acetyl-CoA carboxylase inhibitor ND-654 and sorafenib improves efficacy in the treatment of cirrhotic rats with hepatocellular carcinoma","volume":"76","author":"Wei","year":"2016","journal-title":"Cancer Res."},{"key":"ref_118","first-page":"7330","article-title":"Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells","volume":"63","author":"Zhou","year":"2003","journal-title":"Cancer Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2217\/fon.10.11","article-title":"Fatty acid synthase as a potential therapeutic target in cancer","volume":"6","author":"Flavin","year":"2010","journal-title":"Future Oncol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jhep.2017.06.015","article-title":"Stearoyl-CoA desaturase regulates sorafenib resistance via modulation of ER stress-induced differentiation","volume":"67","author":"Ma","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"G598","DOI":"10.1152\/ajpgi.00061.2018","article-title":"TO901317 inhibits the development of hepatocellular carcinoma by LXRalpha\/Glut1 decreasing glycometabolism","volume":"316","author":"Xiong","year":"2019","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1158\/0008-5472.CAN-07-6161","article-title":"Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma","volume":"68","author":"Montero","year":"2008","journal-title":"Cancer Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/jcmm.16235","article-title":"ATP citrate lyase inhibitor triggers endoplasmic reticulum stress to induce hepatocellular carcinoma cell apoptosis via p-eIF2 alpha\/ATF4\/CHOP axis","volume":"25","author":"Zheng","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/biology4010104","article-title":"Lipids around the Clock: Focus on Circadian Rhythms and Lipid Metabolism","volume":"4","author":"Gnocchi","year":"2015","journal-title":"Biology"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Gnocchi, D., and Bruscalupi, G. (2017). Circadian Rhythms and Hormonal Homeostasis: Pathophysiological Implications. Biology, 6.","DOI":"10.3390\/biology6010010"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00109-019-01780-2","article-title":"Circadian rhythms: A possible new player in non-alcoholic fatty liver disease pathophysiology","volume":"97","author":"Gnocchi","year":"2019","journal-title":"J. Mol. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.1038\/oncsis.2017.21","article-title":"MAGE-TRIM28 complex promotes the Warburg effect and hepatocellular carcinoma progression by targeting FBP1 for degradation","volume":"6","author":"Jin","year":"2017","journal-title":"Oncogenesis"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"43864","DOI":"10.1038\/srep43864","article-title":"Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1021\/bi0618621","article-title":"trans-2-phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1","volume":"46","author":"Schmidt","year":"2007","journal-title":"Biochemistry"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Pan, D.N., Mao, C.X., and Wang, Y.X. (2013). Suppression of Gluconeogenic Gene Expression by LSD1-Mediated Histone Demethylation. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0066294"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1038\/ncomms3508","article-title":"Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma","volume":"4","author":"Ma","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"10551","DOI":"10.1021\/jm301191p","article-title":"Design, Synthesis, and Pharmacological Evaluation of Bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl Sulfide 3 (BPTES) Analogs as Glutaminase Inhibitors","volume":"55","author":"Shukla","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1021\/acs.jmedchem.8b01198","article-title":"Novel 1,3,4-Selenadiazole-Containing Kidney-Type Glutaminase Inhibitors Showed Improved Cellular Uptake and Antitumor Activity","volume":"62","author":"Chen","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nm.4464","article-title":"Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models","volume":"24","author":"Schulte","year":"2018","journal-title":"Nat. Med."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e56749","DOI":"10.7554\/eLife.56749","article-title":"A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer","volume":"9","author":"Jin","year":"2020","journal-title":"eLife"},{"key":"ref_136","first-page":"1751","article-title":"Berberine Inhibits Growth of Liver Cancer Cells by Suppressing Glutamine Uptake","volume":"12","author":"Zhang","year":"2019","journal-title":"OncoTargets Ther."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Steinberg, G.R., and Hardie, D.G. (2022). New insights into activation and function of the AMPK. Nat. Rev. Mol. Cell Biol.","DOI":"10.1038\/s41580-022-00547-x"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4172\/2167-7689.1000118","article-title":"AMPK Activators as a Drug for Diabetes, Cancer and Cardiovascular Disease","volume":"3","author":"Goodman","year":"2014","journal-title":"Pharm. Regul. Aff."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/1878-0261.13211","article-title":"A novel AMPK activator shows therapeutic potential in hepatocellular carcinoma by suppressing HIF1 alpha-mediated aerobic glycolysis","volume":"16","author":"Tseng","year":"2022","journal-title":"Mol. Oncol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"190099","DOI":"10.1098\/rsob.190099","article-title":"The strange case of AMPK and cancer: Dr Jekyll or Mr Hyde? (dagger)","volume":"9","author":"Russell","year":"2019","journal-title":"Open Biol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1182\/blood-2018-02-831503","article-title":"AMPK-ACC signaling modulates platelet phospholipids and potentiates thrombus formation","volume":"132","author":"Lepropre","year":"2018","journal-title":"Blood"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.thromres.2020.12.002","article-title":"Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease","volume":"198","author":"Ciavarella","year":"2021","journal-title":"Thromb. Res."},{"key":"ref_143","first-page":"1223","article-title":"Evaluation of the cytotoxicity, cell-cycle arrest, and apoptotic induction by Euphorbia hirta in MCF-7 breast cancer cells","volume":"54","author":"Kwan","year":"2016","journal-title":"Pharm. Biol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1017\/S0007114511003308","article-title":"Benefits of whole ginger extract in prostate cancer","volume":"107","author":"Karna","year":"2012","journal-title":"Br. J. Nutr."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11130-008-0074-z","article-title":"Methanolic extracts of Uncaria rhynchophylla induce cytotoxicity and apoptosis in HT-29 human colon carcinoma cells","volume":"63","author":"Jo","year":"2008","journal-title":"Plant Foods Hum. Nutr."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2174\/1568026620666200224100219","article-title":"Plant Extracts and their Secondary Metabolites as Modulators of Kinases","volume":"20","author":"Gill","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s11130-011-0256-y","article-title":"Anti-proliferative effect of Melissa officinalis on human colon cancer cell line","volume":"66","author":"Encalada","year":"2011","journal-title":"Plant Foods Hum. Nutr."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/iub.47","article-title":"Resveratrol: One molecule, many targets","volume":"60","author":"Pirola","year":"2008","journal-title":"IUBMB Life"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbagen.2011.10.005","article-title":"Effects of resveratrol on HepG2 cells as revealed by H-1-NMR based metabolic profiling","volume":"1820","author":"Massimi","year":"2012","journal-title":"Biochim. Biophys. Acta (BBA)-Gen. Subj."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"36034","DOI":"10.1039\/C8RA05092A","article-title":"Resveratrol metabolites ameliorate insulin resistance in HepG2 hepatocytes by modulating IRS-1\/AMPK","volume":"8","author":"Teng","year":"2018","journal-title":"RSC Adv."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/s41598-020-78867-1","article-title":"1H-NMR metabolomics reveals a multitarget action of Crithmum maritimum ethyl acetate extract in inhibiting hepatocellular carcinoma cell growth","volume":"11","author":"Gnocchi","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s11130-022-00986-z","article-title":"The Edible Plant Crithmum maritimum Shows Nutraceutical Properties by Targeting Energy Metabolism in Hepatic Cancer","volume":"77","author":"Gnocchi","year":"2022","journal-title":"Plant Foods Hum. Nutr."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Gnocchi, D., Sabba, C., and Mazzocca, A. (2022). Crithmum maritimum Improves Sorafenib Sensitivity by Decreasing Lactic Acid Fermentation and Inducing a Pro-Hepatocyte Marker Profile in Hepatocellular Carcinoma. Plant Foods Hum. Nutr.","DOI":"10.1007\/s11130-022-01037-3"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/jpp\/rgab070","article-title":"Treatment of liver cancer cells with ethyl acetate extract of Crithmum maritimum permits reducing sorafenib dose and toxicity maintaining its efficacy","volume":"73","author":"Gnocchi","year":"2021","journal-title":"J. Pharm. Pharm."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.bbrc.2020.04.036","article-title":"A distinctive protein signature induced by lysophosphatidic acid receptor 6 (LPAR6) expression in hepatocellular carcinoma cells","volume":"526","author":"Lippolis","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.biochi.2022.07.016","article-title":"Inhibition of LPAR6 overcomes sorafenib resistance by switching glycolysis into oxidative phosphorylation in hepatocellular carcinoma","volume":"202","author":"Gnocchi","year":"2022","journal-title":"Biochimie"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00109-019-01862-1","article-title":"Novel lysophosphatidic acid receptor 6 antagonists inhibit hepatocellular carcinoma growth through affecting mitochondrial function","volume":"98","author":"Gnocchi","year":"2020","journal-title":"J. Mol. Med."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/cmdc.202100032","article-title":"Xanthenylacetic Acid Derivatives Effectively Target Lysophosphatidic Acid Receptor 6 to Inhibit Hepatocellular Carcinoma Cell Growth","volume":"16","author":"Gnocchi","year":"2021","journal-title":"ChemMedChem"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1158\/0008-5472.CAN-14-1607","article-title":"Lysophosphatidic acid receptor LPAR6 supports the tumorigenicity of hepatocellular carcinoma","volume":"75","author":"Mazzocca","year":"2015","journal-title":"Cancer Res."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/hep.24485","article-title":"Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts","volume":"54","author":"Mazzocca","year":"2011","journal-title":"Hepatology"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Gnocchi, D., Sabba, C., and Mazzocca, A. (2023). Lactic acid fermentation: A maladaptive mechanism and an evolutionary throwback boosting cancer drug resistance. Biochimie.","DOI":"10.1016\/j.biochi.2023.01.005"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"101510","DOI":"10.1016\/j.redox.2020.101510","article-title":"Integrated molecular signaling involving mitochondrial dysfunction and alteration of cell metabolism induced by tyrosine kinase inhibitors in cancer","volume":"36","author":"Negrete","year":"2020","journal-title":"Redox Biol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"113902","DOI":"10.1016\/j.bcp.2020.113902","article-title":"Dose-dependent regulation of mitochondrial function and cell death pathway by sorafenib in liver cancer cells","volume":"176","author":"Gallego","year":"2020","journal-title":"Biochem. Pharm."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41419-020-2558-1","article-title":"Differential effectiveness of tyrosine kinase inhibitors in 2D\/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells","volume":"11","author":"Cadenas","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"102699","DOI":"10.1016\/j.ebiom.2020.102699","article-title":"Severe metabolic alterations in liver cancer lead to ERK pathway activation and drug resistance","volume":"54","author":"Nwosu","year":"2020","journal-title":"EBioMedicine"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/4\/3710\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:32:54Z","timestamp":1760121174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/4\/3710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,13]]},"references-count":165,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["ijms24043710"],"URL":"https:\/\/doi.org\/10.3390\/ijms24043710","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,13]]}}}